Harbor Health Care ETF (MEDI)
NYSEARCA: MEDI · Real-Time Price · USD
36.09
-0.02 (-0.05%)
Nov 10, 2026, 4:00 PM EST - Market closed
| Assets | $41.78M |
| Expense Ratio | 0.80% |
| PE Ratio | 29.63 |
| Forward PE | 30.03 |
| Shares Out | 1.30M |
| Dividend | $0.08 (0.21%) |
| Ex-Dividend Date | Dec 19, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 6.45% |
| Volume | 7,460 |
| Open | 36.01 |
| Previous Close | 36.11 |
| Day's Range | 36.01 - 36.01 |
| 52-Week Low | 27.50 |
| 52-Week High | 36.36 |
| Beta | 0.65 |
| Holdings | 45 |
| Inception Date | Nov 16, 2022 |
About MEDI
Fund Home PageThe Harbor Health Care ETF (MEDI) is an exchange-traded fund that mostly invests in health care stocks. The fund seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally. MEDI was launched on Nov 16, 2022 and is issued by Harbor.
Top 10 Holdings
63.78% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 20.68% |
| Ascendis Pharma A/S | ASND | 16.76% |
| argenx SE | ARGX | 4.95% |
| Rhythm Pharmaceuticals, Inc. | RYTM | 4.10% |
| Vaxcyte, Inc. | PCVX | 3.52% |
| Guardant Health, Inc. | GH | 3.15% |
| Insmed Incorporated | INSM | 3.10% |
| Revolution Medicines, Inc. | RVMD | 2.81% |
| IDEXX Laboratories, Inc. | IDXX | 2.51% |
| United Therapeutics Corporation | UTHR | 2.19% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2025 | $0.07515 | Dec 24, 2025 |
| Dec 20, 2024 | $0.13455 | Dec 26, 2024 |
| Dec 21, 2023 | $0.4613 | Dec 27, 2023 |
Performance
MEDI had a total return of 21.61% in the past year, including dividends. Since the fund's inception, the average annual return has been 17.09%.
News
Harbor Capital Celebrates 3-Year Anniversary of Harbor Health Care ETF (MEDI)
CHICAGO--(BUSINESS WIRE)--Harbor Capital Advisors, Inc. (“Harbor”), a premier provider of investment solutions, is proud to celebrate the 3-year anniversary of the Harbor Health Care ETF (MEDI), an ac...
11 months ago - Business Wire
